These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

883 related articles for article (PubMed ID: 25581748)

  • 1. Maturity-onset diabetes of the young (MODY): an update.
    Anık A; Çatlı G; Abacı A; Böber E
    J Pediatr Endocrinol Metab; 2015 Mar; 28(3-4):251-63. PubMed ID: 25581748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha (HNF1A) and 4 alpha (HNF4A) in maturity-onset diabetes of the young.
    Ellard S; Colclough K
    Hum Mutat; 2006 Sep; 27(9):854-69. PubMed ID: 16917892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maturity onset diabetes of the young: identification and diagnosis.
    McDonald TJ; Ellard S
    Ann Clin Biochem; 2013 Sep; 50(Pt 5):403-15. PubMed ID: 23878349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maturity Onset Diabetes of the Young due to Glucokinase, HNF1-A, HNF1-B, and HNF4-A Mutations in a Cohort of Turkish Children Diagnosed as Type 1 Diabetes Mellitus.
    Ozsu E; Cizmecioglu FM; Yesiltepe Mutlu G; Yuksel AB; Calıskan M; Yesilyurt A; Hatun S
    Horm Res Paediatr; 2018; 90(4):257-265. PubMed ID: 30481753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and management of maturity-onset diabetes of the young.
    Timsit J; Bellanné-Chantelot C; Dubois-Laforgue D; Velho G
    Treat Endocrinol; 2005; 4(1):9-18. PubMed ID: 15649097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and laboratory clues of maturity-onset diabetes of the young and determination of association with molecular diagnosis.
    Karaoglan M; Nacarkahya G
    J Diabetes; 2021 Feb; 13(2):154-163. PubMed ID: 32710514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, characteristics and clinical diagnosis of maturity onset diabetes of the young due to mutations in HNF1A, HNF4A, and glucokinase: results from the SEARCH for Diabetes in Youth.
    Pihoker C; Gilliam LK; Ellard S; Dabelea D; Davis C; Dolan LM; Greenbaum CJ; Imperatore G; Lawrence JM; Marcovina SM; Mayer-Davis E; Rodriguez BL; Steck AK; Williams DE; Hattersley AT;
    J Clin Endocrinol Metab; 2013 Oct; 98(10):4055-62. PubMed ID: 23771925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maturity Onset Diabetes of the Young (MODY) in Tunisia: Low frequencies of GCK and HNF1A mutations.
    Ben Khelifa S; Martinez R; Dandana A; Khochtali I; Ferchichi S; Castaño L
    Gene; 2018 Apr; 651():44-48. PubMed ID: 29408271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Who should have genetic testing for maturity-onset diabetes of the young?
    Naylor R; Philipson LH
    Clin Endocrinol (Oxf); 2011 Oct; 75(4):422-6. PubMed ID: 21521318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of HNF1A-MODY and HNF4A-MODY in Irish families: phenotypic characteristics and therapeutic implications.
    Kyithar MP; Bacon S; Pannu KK; Rizvi SR; Colclough K; Ellard S; Byrne MM
    Diabetes Metab; 2011 Dec; 37(6):512-9. PubMed ID: 21683639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic assessment of etiology in adults with a clinical diagnosis of young-onset type 2 diabetes is a successful strategy for identifying maturity-onset diabetes of the young.
    Thanabalasingham G; Pal A; Selwood MP; Dudley C; Fisher K; Bingley PJ; Ellard S; Farmer AJ; McCarthy MI; Owen KR
    Diabetes Care; 2012 Jun; 35(6):1206-12. PubMed ID: 22432108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary C-peptide creatinine ratio is a practical outpatient tool for identifying hepatocyte nuclear factor 1-{alpha}/hepatocyte nuclear factor 4-{alpha} maturity-onset diabetes of the young from long-duration type 1 diabetes.
    Besser RE; Shepherd MH; McDonald TJ; Shields BM; Knight BA; Ellard S; Hattersley AT
    Diabetes Care; 2011 Feb; 34(2):286-91. PubMed ID: 21270186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maturity onset diabetes of the young: Seek and you will find.
    Heuvel-Borsboom H; de Valk HW; Losekoot M; Westerink J
    Neth J Med; 2016 Jun; 74(5):193-200. PubMed ID: 27323672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha and 4 alpha in maturity-onset diabetes of the young and hyperinsulinemic hypoglycemia.
    Colclough K; Bellanne-Chantelot C; Saint-Martin C; Flanagan SE; Ellard S
    Hum Mutat; 2013 May; 34(5):669-85. PubMed ID: 23348805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypical aspects of maturity-onset diabetes of the young (MODY diabetes) in comparison with Type 2 diabetes mellitus (T2DM) in children and adolescents: experience from a large multicentre database.
    Schober E; Rami B; Grabert M; Thon A; Kapellen T; Reinehr T; Holl RW;
    Diabet Med; 2009 May; 26(5):466-73. PubMed ID: 19646184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Half of clinically defined maturity-onset diabetes of the young patients in Denmark do not have mutations in HNF4A, GCK, and TCF1.
    Johansen A; Ek J; Mortensen HB; Pedersen O; Hansen T
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4607-14. PubMed ID: 15928245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive molecular analysis of Japanese patients with pediatric-onset MODY-type diabetes mellitus.
    Yorifuji T; Fujimaru R; Hosokawa Y; Tamagawa N; Shiozaki M; Aizu K; Jinno K; Maruo Y; Nagasaka H; Tajima T; Kobayashi K; Urakami T
    Pediatr Diabetes; 2012 Feb; 13(1):26-32. PubMed ID: 22060211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating ghrelin level is higher in HNF1A-MODY and GCK-MODY than in polygenic forms of diabetes mellitus.
    Nowak N; Hohendorff J; Solecka I; Szopa M; Skupien J; Kiec-Wilk B; Mlynarski W; Malecki MT
    Endocrine; 2015 Dec; 50(3):643-9. PubMed ID: 25987348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maturity-onset diabetes of the young: clinical heterogeneity explained by genetic heterogeneity.
    Hattersley AT
    Diabet Med; 1998 Jan; 15(1):15-24. PubMed ID: 9472859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maturity onset diabetes of the young (MODY) in Chinese children: genes and clinical phenotypes.
    Ming-Qiang Z; Yang-Li D; Ke H; Wei W; Jun-Fen F; Chao-Chun Z; Guan-Ping D
    J Pediatr Endocrinol Metab; 2019 Jul; 32(7):759-765. PubMed ID: 31216263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.